<?xml version="1.0"?>
<rss version="2.0">
<channel>
<title>Inbox Robot: Boehringer Ingelheim News</title>
<link>http://www.inboxrobot.com/news/boehringer-ingelheim</link><description>Constantly updated news and information about a variety of topics.</description><item>
<title>FDA Says Spiriva Trial Results Show No Increased Risk</title>
<link>http://www.inboxrobot.com/news.php?fid=192545384</link>
<pubDate>10 Oct 2008 22:29 GMT</pubDate>
<description>
...  Results Show No Increased Risk The FDA expects a complete report in November from Boehringer Ingelheim on the study Understanding Potential Long-term Impacts on Function with Tiotropium (UPLIFT). This article  ...
</description>
</item><item>
<title>Boehringer Ingelheim Gets Warning for Mirapex Ads</title>
<link>http://www.inboxrobot.com/news.php?fid=192545364</link>
<pubDate>10 Oct 2008 22:29 GMT</pubDate>
<description>
... &gt; Boehringer Ingelheim Gets Warning for Mirapex Ads Oct. 13, 2008 | Vol. 40 No. 40 Boehringer  ...
</description>
</item><item>
<title>Genentech Regains &quot;Title&quot; As Best Biopharma Employer</title>
<link>http://www.inboxrobot.com/news.php?fid=192504765</link>
<pubDate>10 Oct 2008 17:31 GMT</pubDate>
<description>
...  the first five years of the survey, but fell to #2 last year, behind Boehringer Ingelheim which dropped to #4 this year. As an aside, shares of DNA were briefly  ...
</description>
</item><item>
<title>HIV Commercial Insight: The Battle for the $9.3 Billion Market Share is Getting Fiercer</title>
<link>http://www.inboxrobot.com/news.php?fid=192477540</link>
<pubDate>10 Oct 2008 15:30 GMT</pubDate>
<description>
...  Gilead - GlaxoSmithKline - Tibotec - Bristol Myers Squibb - Abbott - Roche - Boehringer Ingelheim - Merck For more information visit ...
</description>
</item><item>
<title>Drug Access - Drug Companies Plan To Invest in HIV/AIDS Drug Development, Improve Access, U.N. Secretary-General Say</title>
<link>http://www.inboxrobot.com/news.php?fid=192474415</link>
<pubDate>10 Oct 2008 14:50 GMT</pubDate>
<description>
...  Ban Ki-moon on Thursday said that many large pharmaceutical companies -- including Abbott Labs, Boehringer Ingelheim, GlaxoSmithKline and Pfizer -- plan to increase their efforts to develop HIV/AIDS drugs and  ...
</description>
</item><item>
<title>Firms to pump in more funds into Aids research</title>
<link>http://www.inboxrobot.com/news.php?fid=192448965</link>
<pubDate>10 Oct 2008 12:19 GMT</pubDate>
<description>
...  Ban and other U.N. officials met with were from 17 companies, including Abbott Labs, Boehringer Ingelheim, GlaxoSmithKline, Pfizer and other top industry players. Ban said the companies agreed to &quot;invest  ...
</description>
</item><item>
<title>Drug firms agree to invest more in AIDS research: U.N.</title>
<link>http://www.inboxrobot.com/news.php?fid=192379158</link>
<pubDate>10 Oct 2008 00:38 GMT</pubDate>
<description>
...  Ban and other U.N. officials met with were from 17 companies, including Abbott Labs, Boehringer Ingelheim, GlaxoSmithKline, Pfizer and other top industry players. Ban said the companies agreed to &quot;invest  ...
</description>
</item><item>
<title>Boehringer Ingelheim Developing New Drugs As Patents Wane</title>
<link>http://www.inboxrobot.com/news.php?fid=192246941</link>
<pubDate>9 Oct 2008 17:29 GMT</pubDate>
<description>
... Chemist Zhonghua Zhang works with chemical compounds in a rotary evaporator at Boehringer Ingelheim Pharmaceuticals in Ridgefield. RIDGEFIELD - The sprawling campus of Boehringer Ingelheim Pharmaceuticals exudes the  ...
</description>
</item><item>
<title>Drug Company Develops New Products As Patents Wane</title>
<link>http://www.inboxrobot.com/news.php?fid=192224953</link>
<pubDate>9 Oct 2008 16:44 GMT</pubDate>
<description>
... Chemist Zhonghua Zhang works with chemical compounds in a rotary evaporator at Boehringer Ingelheim Pharmaceuticals in Ridgefield. RIDGEFIELD - The sprawling campus of Boehringer Ingelheim Pharmaceuticals exudes the  ...
</description>
</item><item>
<title>Extending time of stroke drug treatment OK</title>
<link>http://www.inboxrobot.com/news.php?fid=192208541</link>
<pubDate>9 Oct 2008 16:32 GMT</pubDate>
<description>
...  percent. The death rate was similar in both groups. The study was funded by Boehringer Ingelheim Pharmaceuticals Inc., which markets TPA as Actilyse overseas. TPA is sold in North America  ...
</description>
</item><item>
<title>A Report on Brazil&apos;s Pharmaceuticals and Healthcare Market for Q3 2008 - Examine the Opportunities in One of the Largest &amp; Most Dynamic Markets in the World</title>
<link>http://www.inboxrobot.com/news.php?fid=192167420</link>
<pubDate>9 Oct 2008 07:30 GMT</pubDate>
<description>
...  giant Ranbaxy saw sales growth of 75% in Brazil in Q108. Novo Nordisk and Boehringer Ingelheim have become other major exporters. Brazil&apos;s route to a more favourable trade balance remains  ...
</description>
</item><item>
<title>Data Show No Stroke Risk With Spiriva: FDA</title>
<link>http://www.inboxrobot.com/news.php?fid=192151410</link>
<pubDate>9 Oct 2008 05:37 GMT</pubDate>
<description>
...  to treat chronic obstructive pulmonary disease, or COPD, and is co-marketed by Pfizer and Boehringer Ingelheim, a privately held German company. ...
</description>
</item><item>
<title>Independent Pharmacies Rank Highest Nationally in Overall Customer Satisfaction</title>
<link>http://www.inboxrobot.com/news.php?fid=192147580</link>
<pubDate>9 Oct 2008 05:29 GMT</pubDate>
<description>
...  the retail pharmacy industry, according to the first Independent Pharmacy Satisfaction Report presented by Boehringer Ingelheim Pharmaceuticals, Inc. In fact, 69 percent of independent pharmacy customers in the United States  ...
</description>
</item><item>
<title>New Survey Highlights People with Parkinson&apos;s and Caregivers&apos; Needs</title>
<link>http://www.inboxrobot.com/news.php?fid=192128116</link>
<pubDate>9 Oct 2008 04:04 GMT</pubDate>
<description>
...  Parkinson&apos;s disease. The &quot;Parkinson&apos;s Knowledge and Needs Exchange&quot; survey was commissioned and funded by Boehringer Ingelheim Pharmaceuticals, Inc. GfK Roper Public Affairs &amp; Media designed and conducted the survey on  ...
</description>
</item><item>
<title>Research and Markets: A Report on Brazil&apos;s Pharmaceuticals and Healthcare Market for Q3 2008 - Examine the Opportunities in One of the Largest &amp; Most Dynamic Markets in the World</title>
<link>http://www.inboxrobot.com/news.php?fid=192115182</link>
<pubDate>9 Oct 2008 02:18 GMT</pubDate>
<description>
...  giant Ranbaxy saw sales growth of 75% in Brazil in Q108. Novo Nordisk and Boehringer Ingelheim have become other major exporters. Brazil s route to a more favourable trade balance  ...
</description>
</item></channel>
</rss>
